Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkad375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von George M Nduva und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Substance Abuse, Intravenous, Sex Workers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, New Partnership for Africa’s Development (NEPAD) Planning, UK government.
Abstract (Originalsprache)
Background
Evidence on the distribution of pre-treatment HIV-1 drug resistance (HIVDR) among risk groups is limited in Africa. We assessed the prevalence, trends and transmission dynamics of pre-treatment HIVDR within and between MSM, people who inject drugs (PWID), female sex workers (FSWs), heterosexuals (HETs) and perinatally infected children in Kenya.
Methods
HIV-1 partial pol sequences from antiretroviral-naive individuals collected from multiple sources between 1986 and 2020 were used. Pre-treatment reverse transcriptase inhibitor (RTI), PI and integrase inhibitor (INSTI) mutations were assessed using the Stanford HIVDR database. Phylogenetic methods were used to determine and date transmission clusters.
Results
Of 3567 sequences analysed, 550 (15.4%, 95% CI: 14.2–16.6) had at least one pre-treatment HIVDR mutation, which was most prevalent amongst children (41.3%), followed by PWID (31.0%), MSM (19.9%), FSWs (15.1%) and HETs (13.9%). Overall, pre-treatment HIVDR increased consistently, from 6.9% (before 2005) to 24.2% (2016–20). Among HETs, pre-treatment HIVDR increased from 6.6% (before 2005) to 20.2% (2011–15), but dropped to 6.5% (2016–20). Additionally, 32 clusters with shared pre-treatment HIVDR mutations were identified. The majority of clusters had R0 ≥ 1.0, indicating ongoing transmissions. The largest was a K103N cluster involving 16 MSM sequences sampled between 2010 and 2017, with an estimated time to the most recent common ancestor (tMRCA) of 2005 [95% higher posterior density (HPD), 2000–08], indicating propagation over 12 years.
Conclusions
Compared to HETs, children and key populations had higher levels of pre-treatment HIVDR. Introduction of INSTIs after 2017 may have abrogated the increase in pre-treatment RTI mutations, albeit in the HET population only. Taken together, our findings underscore the need for targeted efforts towards equitable access to ART for children and key populations in Kenya.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, Lund University, Lund, Sweden.
- Department of HIV/STI, KEMRI/Wellcome Trust Research Programme, PO Box 230-80108 Kilifi, Kenya.
- Nyanza Reproductive Health Society, Kisumu, Kenya.
- Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
ORCID-Profile: Susan M Graham, Joakim Esbjörnsson, Amin S Hassan
Förderung
- Wellcome Trust
- New Partnership for Africa’s Development (NEPAD) Planning
- UK government
- Swedish Research Council
- Swedish Society for Medical Research
- IAVI
Zitieren
APA
Nduva, G. M., Otieno, F., Kimani, J., Sein, Y., Arimide, D. A., Mckinnon, L. R., Cholette, F., Lawrence, M. K., Majiwa, M., Masika, M., Mutua, G., Anzala, O., Graham, S. M., Gelmon, L., Price, M. A., Smith, A. D., Bailey, R. C., Medstrand, P., Sanders, E. J., …, & Hassan, A. S. (2024). Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad375
Vancouver
Nduva GM, Otieno F, Kimani J, Sein Y, Arimide DA, Mckinnon LR, et al. Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkad375
BibTeX
@article{Nduva2024,
author = {Nduva, George M and Otieno, Frederick and Kimani, Joshua and Sein, Yiakon and Arimide, Dawit A and Mckinnon, Lyle R and Cholette, Francois and Lawrence, Morris K and Majiwa, Maxwell and Masika, Moses and Mutua, Gaudensia and Anzala, Omu and Graham, Susan M and Gelmon, Larry and Price, Matt A and Smith, Adrian D and Bailey, Robert C and Medstrand, Patrik and Sanders, Eduard J and Esbjörnsson, Joakim and Hassan, Amin S},
title = {Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkad375}
}
EUVIMED